1. Home
  2. LEDS vs BOLT Comparison

LEDS vs BOLT Comparison

Compare LEDS & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SemiLEDS Corporation

LEDS

SemiLEDS Corporation

HOLD

Current Price

$1.98

Market Cap

12.3M

Sector

Technology

ML Signal

HOLD

Logo Bolt Biotherapeutics Inc.

BOLT

Bolt Biotherapeutics Inc.

HOLD

Current Price

$6.45

Market Cap

10.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEDS
BOLT
Founded
2005
2015
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.3M
10.5M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
LEDS
BOLT
Price
$1.98
$6.45
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$34.00
AVG Volume (30 Days)
19.9K
25.0K
Earning Date
01-14-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$44,317,000.00
$5,195,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
824.43
N/A
52 Week Low
$1.27
$4.41
52 Week High
$3.37
$11.70

Technical Indicators

Market Signals
Indicator
LEDS
BOLT
Relative Strength Index (RSI) 54.44 71.18
Support Level $1.48 $5.61
Resistance Level $2.17 $6.09
Average True Range (ATR) 0.13 0.33
MACD 0.06 0.07
Stochastic Oscillator 75.46 92.09

Price Performance

Historical Comparison
LEDS
BOLT

About LEDS SemiLEDS Corporation

SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

Share on Social Networks: